Most recently, it has been determined that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in similar locations as classical opioid receptors, it binds to a big range of endogenous opioids. Unlike most opioid receptors, this receptor acts as being a scavenger https://johnq296xjv7.ziblogs.com/profile